- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Life360, Inc. Bottom Line Rises In Q4 | ||
| Mo | Sturm, Ruger Swings To Loss In 2025 | ||
| Mo | Capstone Copper Corp. Bottom Line Advances In Q4 | ||
| Mo | Turbo Energy Shares Skyrocket 76% On Industrial Electrification Push | ||
| Mo | UniQure Says FDA Rejects Phase I/II Data As Sufficient For AMT-130 Filing | ||
| Mo | Arizona Sonoran Copper Shares Surge 25% On Hudbay Acquisition Deal | ||
| Mo | Kratos Defense Shares Rise 9% On OpenSpace Platform Deployment With SSC Space | ||
| Mo | Klaviyo Authorizes $500 Mln Share Repurchase | ||
| Mo | UniQure Shares Plunge 37% After FDA Feedback And FY25 Results | ||
| Mo | Battalion Oil Shares Soar 64% | ||
| Mo | UniQure Says FDA Rejects AMT-130 Phase I/II Studies Data; Stock Plunges 42% | ||
| Mo | STEALTHGAS INC Reveals Drop In Q4 Bottom Line | ||
| Mo | Dyne Therapeutics Posts Wider Loss In Q4 | ||
| Mo | Novo Nordisk To Invest €432 Million In Ireland Facility To Expand Oral GLP-1 Production | ||
| Mo | EchoStar Slips To Loss In Q4 On Charges, Weak Revenues | ||
| Mo | Turning Point Brands. Inc Announces Climb In Full Year Bottom Line | ||
| Mo | ADMA Biologics Announces $200 Mln Capital Return Plan | ||
| Mo | California Resources Corporation Q4 Profit Drops | ||
| Mo | Agios Pharma's PYRUKYND Approved In UAE For Alpha- And Beta-Thalassemia | ||
| Mo | Intellia: FDA Removes Clinical Hold On IND For MAGNITUDE Phase 3 Trial Of Nexiguran Ziclumeran | ||
| Mo | Neogen To Sell Genomics Business To Zoetis For $160 Mln | ||
| Mo | TEGNA Inc. Profit Falls In Q4 | ||
| Mo | Aaon Inc. Q4 Profit Advances | ||
| Mo | Hudbay To Acquire Arizona Sonoran Copper In $1.48 Bln All Share Deal | ||
| Mo | ADT Inc. Profit Drops In Q4 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.